FDA approves Merck's Zinplava to reduce recurrence of Clostridium difficile infection
International pharmaceutical company Merck has announced that the U.S. Food and Drug Administration (FDA) has approved Zinplava (its brand name for bezlotoxumab) to reduce recurrence of Clostridium difficile infection (CDI) ...
Oct 25, 2016
0
2